QA: Axsome Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001579428_2023_Axsome_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001579428, Axsome Therapeutics Inc.

  xvar xval
0 AssetsCurrent 245,641,409
1 IntangibleAssetsNetIncludingGoodwill 69,970,772
2 PropertyPlantAndEquipmentNet 722,515
3 remainder_Assets 15,141,399
4 LiabilitiesCurrent 96,560,798
5 LiabilitiesNoncurrent 94,258,888
6 remainder_Liabilities 31,100,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 159,253,661
9 ResearchAndDevelopmentExpense 57,947,447
10 remainder_Expenses 12,635,053
11 remainder_Revenues 50,037,106
12 remainder_NetIncome -7,334,596
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 331,476,095
1 Liabilities 221,919,686
2 Expenses 229,836,161
3 Revenues 50,037,106
4 StockholdersEquity 109,556,409
5 NetIncome -187,133,651
6 ComprehensiveNetIncome -187,133,651
7 BaseVar 420,301,822
8 EconomicCapitalRatio 0.00471

Edgar->Model Mapping

Feature Distribution

Change over Time